Ginkgo Bioworks Promotes Coen to CFO, Succeeding Dmytruk

Dow Jones

2025/05/22

By Connor Hart

Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role.

Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday.

Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo.

Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte & Touche.

As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

May 21, 2025 17:08 ET (21:08 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2537548079"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537548079\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537548079?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 05:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537548079","market":"sg","top_or_hot":-1,"title":"Ginkgo Bioworks Promotes Coen to CFO, Succeeding Dmytruk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<p>\n  Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role. \n</p>\n<p>\n  Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday. \n</p>\n<p>\n  Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo. \n</p>\n<p>\n  Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte &amp; Touche. \n</p>\n<p>\n  As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock. \n</p>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 21, 2025 17:08 ET (21:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ginkgo Bioworks Promotes Coen to CFO, Succeeding Dmytruk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGinkgo Bioworks Promotes Coen to CFO, Succeeding Dmytruk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-22 05:08</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<p>\n  Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role. \n</p>\n<p>\n  Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday. \n</p>\n<p>\n  Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo. \n</p>\n<p>\n  Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte &amp; Touche. \n</p>\n<p>\n  As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock. \n</p>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 21, 2025 17:08 ET (21:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4109","symbol_name":"特種化學制品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2537548079","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537548079","pubTimestamp":1747861680,"columns":[{"name":"高層變動","id":29,"label_key":"executive"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role.Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday.Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo.Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte & Touche.As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4109":"特种化学制品","DNA":"Ginkgo Bioworks Holdings Inc.","BK4139":"生物科技"},"translate_title":"Ginkgo Bioworks晋升Coen为首席财务官，接替Dmytruk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DNA":0.9},"content_text":"By Connor Hart \n\n\n  Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role. \n\n\n  Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday. \n\n\n  Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo. \n\n\n  Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte & Touche. \n\n\n  As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock. \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2025 17:08 ET (21:08 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}